Kraft, M.; Foerster, K.I.; Wiedmann, F.; Sauter, M.; Paasche, A.; Blochberger, P.L.; Yesilgöz, B.; L’hoste, Y.; Frey, N.; Haefeli, W.E.;
et al. Simultaneous Quantification and Pharmacokinetic Characterization of Doxapram and 2-Ketodoxapram in Porcine Plasma and Brain Tissue. Pharmaceutics 2022, 14, 762.
https://doi.org/10.3390/pharmaceutics14040762
AMA Style
Kraft M, Foerster KI, Wiedmann F, Sauter M, Paasche A, Blochberger PL, Yesilgöz B, L’hoste Y, Frey N, Haefeli WE,
et al. Simultaneous Quantification and Pharmacokinetic Characterization of Doxapram and 2-Ketodoxapram in Porcine Plasma and Brain Tissue. Pharmaceutics. 2022; 14(4):762.
https://doi.org/10.3390/pharmaceutics14040762
Chicago/Turabian Style
Kraft, Manuel, Kathrin I. Foerster, Felix Wiedmann, Max Sauter, Amelie Paasche, Pablo L. Blochberger, Baran Yesilgöz, Yannick L’hoste, Norbert Frey, Walter E. Haefeli,
and et al. 2022. "Simultaneous Quantification and Pharmacokinetic Characterization of Doxapram and 2-Ketodoxapram in Porcine Plasma and Brain Tissue" Pharmaceutics 14, no. 4: 762.
https://doi.org/10.3390/pharmaceutics14040762
APA Style
Kraft, M., Foerster, K. I., Wiedmann, F., Sauter, M., Paasche, A., Blochberger, P. L., Yesilgöz, B., L’hoste, Y., Frey, N., Haefeli, W. E., Burhenne, J., & Schmidt, C.
(2022). Simultaneous Quantification and Pharmacokinetic Characterization of Doxapram and 2-Ketodoxapram in Porcine Plasma and Brain Tissue. Pharmaceutics, 14(4), 762.
https://doi.org/10.3390/pharmaceutics14040762
